The Use of Ivermectin In the Treatment of COVID 19 Patients
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- to evaluate the role of Ivermectin as a line of treatment for COVID 19
研究概览
简要总结
as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment
详细描述
the study will compare the effect of ivermectin in comaprison and addition to the standard mode of care for the COVID 19 patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Asymptomatic mild cases and moderate cases proven to be infected by COVID 19 by viral RNA swap
排除标准
- •Contraindications for the drug: hypersensitivity.
- •Any medications with possible drug interactions.
- •Severe cases.
- •Any malignant condition.
- •Pregnant females.
- •Breast feeding females.
- •Any patient on the following medications: Erdafitinib- Lasmiditan- Quinidine due to potential severe drug interaction.
研究组 & 干预措施
A ivermectin alone
ivermectin will be administarted alone to COVID 19 patients
干预措施: Ivermectin (Drug)
B standard care alone
standard care will be administarted alone
干预措施: Ivermectin (Drug)
C ivermectin added to standard of care
ivermectin will be administarted in adition to standard care
干预措施: Ivermectin (Drug)
结局指标
主要结局
to evaluate the role of Ivermectin as a line of treatment for COVID 19
时间窗: 2 months
the role of ivermectin in the cure of COVID 19 patients
次要结局
- To asses the rate of viral clearance in comparison to other treatment protocols.(2 months)
研究者
Dr. Ehab kamal
general director of fever hospitals
Ministry of Health and Population, Egypt
